Predicts treatment response from a patient's disease profile to point toward the most promising options.
Consented intake · your records travel with you · nothing moves without your sign-off
ArteraAI works on biomarker-drug matching and treatment response prediction. From the disease profile in a patient's test data, it helps identify the treatment options with the most likely effective response and assess confidence in the expected outcome. It is for patients who want treatment recommendations grounded in the best global thinking rather than a single opinion.
The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how ArteraAI handles billing.
We don't have confirmed insurance details for ArteraAI yet. Start a coverage check with your plan, or contact the provider directly.
Answers grounded in ArteraAI's details here. Educational only; your oncologist directs treatment.
Powered by Navis on opencancer.ai
Other providers in similar categories.
Provide a trusted medical context for personalized experiments; contribute to research that will benefit others and hope that new treatments will be identified in time that may help me.
Identify the best treatment ideas using the best global thinking, predict treatment response, assess confidence in outcome
FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.
Tempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.
This page is general information. Upload your records for analysis specific to YOUR diagnosis.